These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 37419127)

  • 1. VLA15, a new global Lyme disease vaccine undergoes clinical trials.
    Hajdusek O; Perner J
    Lancet Infect Dis; 2023 Oct; 23(10):1105-1106. PubMed ID: 37419127
    [No Abstract]   [Full Text] [Related]  

  • 2. The novel Lyme borreliosis vaccine VLA15 shows broad protection against Borrelia species expressing six different OspA serotypes.
    Comstedt P; Schüler W; Meinke A; Lundberg U
    PLoS One; 2017; 12(9):e0184357. PubMed ID: 28863166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lyme vaccine demonized by advocacy groups.
    McSweegan E
    Nature; 2006 Mar; 440(7082):278. PubMed ID: 16541048
    [No Abstract]   [Full Text] [Related]  

  • 4. A brief history of OspA vaccines including their impact on diagnostic testing for Lyme disease.
    Wormser GP
    Diagn Microbiol Infect Dis; 2022 Jan; 102(1):115572. PubMed ID: 34763193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lyme disease.
    Hayes E
    Clin Evid; 2003 Dec; (10):887-99. PubMed ID: 15555127
    [No Abstract]   [Full Text] [Related]  

  • 6. A vaccine against Lyme disease.
    Volkman D
    Health News; 1999 Feb; 5(2):1-2. PubMed ID: 9972105
    [No Abstract]   [Full Text] [Related]  

  • 7. Need for a New Lyme Disease Vaccine.
    Plotkin SA
    N Engl J Med; 2016 Sep; 375(10):911-3. PubMed ID: 27602662
    [No Abstract]   [Full Text] [Related]  

  • 8. Lyme disease: Part II. Management and prevention.
    Bhate C; Schwartz RA
    J Am Acad Dermatol; 2011 Apr; 64(4):639-53; quiz 654, 653. PubMed ID: 21414494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lyme disease vaccine as a strategy for prevention.
    Sood SK
    J Pediatr; 2001 Apr; 138(4):609-10. PubMed ID: 11295736
    [No Abstract]   [Full Text] [Related]  

  • 10. Reactogenicity and immunogenicity of a Lyme disease vaccine in children 2-5 years old.
    Beran J; De Clercq N; Dieussaert I; Van Hoecke C
    Clin Infect Dis; 2000 Dec; 31(6):1504-7. PubMed ID: 11096024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New vaccine targets Lyme disease. New hope for diminishing the 'great masquerader'.
    Lewis C
    FDA Consum; 1999; 33(3):12-7. PubMed ID: 10443184
    [No Abstract]   [Full Text] [Related]  

  • 12. Arthritis following recombinant outer surface protein A vaccination for Lyme disease.
    Rosé CD; Fawcett PT; Gibney KM
    J Rheumatol; 2001 Nov; 28(11):2555-7. PubMed ID: 11708435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic vaccination against Lyme borreliosis for man and dogs and new strategies to treat established B. burgdorferi infections.
    Wallich R; Jahraus O; Simon MM
    Int J Med Microbiol; 2002 Jun; 291 Suppl 33():147-9. PubMed ID: 12141739
    [No Abstract]   [Full Text] [Related]  

  • 14. Lyme disease vaccine.
    Gerber MA
    Pediatr Infect Dis J; 1999 Sep; 18(9):825-6. PubMed ID: 10493347
    [No Abstract]   [Full Text] [Related]  

  • 15. Lyme disease: uphill struggle.
    Abbott A
    Nature; 2006 Feb; 439(7076):524-5. PubMed ID: 16452949
    [No Abstract]   [Full Text] [Related]  

  • 16. Into the woods. New weapons against Lyme disease.
    Peters S
    Adv Nurse Pract; 1999 Oct; 7(10):53-4, 82. PubMed ID: 10808773
    [No Abstract]   [Full Text] [Related]  

  • 17. [Against Lyme borreliosis vaccination also, soon. Until then: antibiotics as early as possible!].
    Bischoff A
    MMW Fortschr Med; 2002 Feb; 144(9):4-6, 8. PubMed ID: 11921651
    [No Abstract]   [Full Text] [Related]  

  • 18. The Lyme disease vaccine--a public health perspective.
    Shen AK; Mead PS; Beard CB
    Clin Infect Dis; 2011 Feb; 52 Suppl 3():s247-52. PubMed ID: 21217171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OspC phylogenetic analyses support the feasibility of a broadly protective polyvalent chimeric Lyme disease vaccine.
    Earnhart CG; Marconi RT
    Clin Vaccine Immunol; 2007 May; 14(5):628-34. PubMed ID: 17360854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inner Workings: Lyme disease vaccines face familiar challenges, both societal and scientific.
    Shaffer L
    Proc Natl Acad Sci U S A; 2019 Sep; 116(39):19214-19217. PubMed ID: 31554734
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.